Loading...
Back to narrative

Update shared on03 Oct 2025

Fair value Increased 2.50%
AnalystConsensusTarget's Fair Value
US$332.75
8.8% overvalued intrinsic discount
03 Oct
US$361.94
Loading
1Y
37.3%
7D
-1.1%

Analysts have raised their price target for Fabrinet from $324.63 to $332.75. This reflects a modest increase as expectations for future performance improve.

What's in the News

  • Fabrinet has completed the repurchase of 107,945 shares between March 29, 2025 and June 27, 2025, valued at $22.26 million. This transaction is part of a broader buyback program, which has totaled 3,874,078 shares and $360.02 million since August 2017 (Key Developments).
  • The company issued earnings guidance for the first fiscal quarter of 2026, expecting revenue between $910 million and $950 million, and GAAP net income per diluted share ranging from $2.48 to $2.63, with approximately 36.1 million diluted shares outstanding (Key Developments).

Valuation Changes

  • Consensus Analyst Price Target has risen slightly, increasing from $324.63 to $332.75.
  • Discount Rate edged up from 8.06% to 8.21%, reflecting a small increase in perceived risk.
  • Revenue Growth projection remains nearly unchanged at approximately 16.3%.
  • Net Profit Margin also remains stable at about 9.99%.
  • Future P/E ratio increased moderately from 25.92x to 26.68x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.